Tonny Solveig Reimers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tonny Solveig Reimers has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Erik Lykke Mortensen
Department of Public Health, University of Copenhagen, Copenhagen, Denmark
2 shared publications Henrik Carstensen
Department of Pediatric Clinic II, The Juliane Marie Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
1 shared publicationJørn Müller
Department of Growth and Reproduction, The Juliane Marie Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
1 shared publicationKjeld Schmiegelow
Department of Pediatric Clinic II, The Juliane Marie Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
1 shared publication- Kjeld Schmiegelow
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Copenhagen, Denmark
1 shared publication Marianne Schmiegelow
Department of Growth and Reproduction, The Juliane Marie Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
1 shared publication
Latest Publications
- 8 March 2006
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 48 (2) , 205-212
Memory deficits in long‐term survivors of childhood brain tumors may primarily reflect general cognitive dysfunctions
Background: To analyze the impact of potential predictors on memory performance in survivors of childhood brain tumors and to examine whether deficits in memory after radiotherapy (RT) should be considered part of a more global mental dysfunction.Procedure: We studied 126 patients with brain tumors diagnosed before the age of 15 years and treated January 1970 through February 1997 in Eastern Denmark. Sixty‐nine of the 126 patients had received RT. In addition to working memory and long‐term memory (LTM), general intelligence (IQ) was assessed.Results: The mean test scores in nearly all memory tests were lower than expected from available norms. In multiple linear regression, treatment with RT, hemisphere tumor location, and hydrocephalus treated with a shunt at the time of diagnosis were found to be significant risk factors for memory deficits. When IQ was included as a covariate, RT did not significantly predict memory performance, while shunt and tumor location remained significant for several but not all tests.Conclusion: These results suggest that in patients treated with RT, memory deficits primarily reflect a general cognitive dysfunction, and it is likely that these intelligence deficits may compromise the chances of success of special memory training. In contrast, memory deficits in non‐irradiated patients may to some degree reflect specific cognitive dysfunctions being most pronounced for patients treated with a shunt and for patients with hemispheric tumors. Pediatr Blood Cancer 2007;48:205–212.
- 8 March 2006
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 48 (2) , 205-212
Memory deficits in long‐term survivors of childhood brain tumors may primarily reflect general cognitive dysfunctions
Background: To analyze the impact of potential predictors on memory performance in survivors of childhood brain tumors and to examine whether deficits in memory after radiotherapy (RT) should be considered part of a more global mental dysfunction.Procedure: We studied 126 patients with brain tumors diagnosed before the age of 15 years and treated January 1970 through February 1997 in Eastern Denmark. Sixty‐nine of the 126 patients had received RT. In addition to working memory and long‐term memory (LTM), general intelligence (IQ) was assessed.Results: The mean test scores in nearly all memory tests were lower than expected from available norms. In multiple linear regression, treatment with RT, hemisphere tumor location, and hydrocephalus treated with a shunt at the time of diagnosis were found to be significant risk factors for memory deficits. When IQ was included as a covariate, RT did not significantly predict memory performance, while shunt and tumor location remained significant for several but not all tests.Conclusion: These results suggest that in patients treated with RT, memory deficits primarily reflect a general cognitive dysfunction, and it is likely that these intelligence deficits may compromise the chances of success of special memory training. In contrast, memory deficits in non‐irradiated patients may to some degree reflect specific cognitive dysfunctions being most pronounced for patients treated with a shunt and for patients with hemispheric tumors. Pediatr Blood Cancer 2007;48:205–212.
- Open Access
- 7 November 2002
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 40 (1) , 26-34
Cognitive deficits in long‐term survivors of childhood brain tumors: Identification of predictive factors
Background: To describe cognitive function and to evaluate the association between potentially predictive factors and cognitive outcome in an unselected population of survivors of childhood brain tumors.Procedure: We studied a consecutive sample of 133 patients (76 had received radiotherapy (RT)) who had a brain tumor diagnosed before the age of 15 years and were treated during the period January 1970 through February 1997 in the Eastern part of Denmark. Biologic effective dose of irradiation (BED) was assessed in 71 patients. One hundred twenty‐seven patients were able to cooperate to WISC‐R and WAIS‐R. Multiple regression models were constructed to evaluate relationships between possible risk factors and cognitive outcome.Results and Conclusions: The mean intelligence (IQ) scores were substantially lower than the expected means of the general population. Younger age at diagnosis, tumor site in cerebral hemisphere, hydrocephalus treated with shunt, and treatment with RT were found to be significant predictors of lower cognitive functions. RT was the most important risk factor for impaired intellectual outcome. The mean observed full scale IQ was 97.1 (SD = 14.3) for the non‐irradiated patients and 78.8 (SD = 14.3) for the irradiated patients (adjusted P < 0.001). Verbal IQ, but not performance and full scale IQ, had a significant negative correlation to BED to the tumor site (P < 0.05). These results can be used to identify subgroups of children who are at increased risk for cognitive deficits allowing early and goal‐directed intervention. Med Pediatr Oncol 2003;40:26–34,
- 7 November 2002
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 40 (1) , 26-34
Open AccessCognitive deficits in long‐term survivors of childhood brain tumors: Identification of predictive factors
Background: To describe cognitive function and to evaluate the association between potentially predictive factors and cognitive outcome in an unselected population of survivors of childhood brain tumors.Procedure: We studied a consecutive sample of 133 patients (76 had received radiotherapy (RT)) who had a brain tumor diagnosed before the age of 15 years and were treated during the period January 1970 through February 1997 in the Eastern part of Denmark. Biologic effective dose of irradiation (BED) was assessed in 71 patients. One hundred twenty‐seven patients were able to cooperate to WISC‐R and WAIS‐R. Multiple regression models were constructed to evaluate relationships between possible risk factors and cognitive outcome.Results and Conclusions: The mean intelligence (IQ) scores were substantially lower than the expected means of the general population. Younger age at diagnosis, tumor site in cerebral hemisphere, hydrocephalus treated with shunt, and treatment with RT were found to be significant predictors of lower cognitive functions. RT was the most important risk factor for impaired intellectual outcome. The mean observed full scale IQ was 97.1 (SD = 14.3) for the non‐irradiated patients and 78.8 (SD = 14.3) for the irradiated patients (adjusted P < 0.001). Verbal IQ, but not performance and full scale IQ, had a significant negative correlation to BED to the tumor site (P < 0.05). These results can be used to identify subgroups of children who are at increased risk for cognitive deficits allowing early and goal‐directed intervention. Med Pediatr Oncol 2003;40:26–34,